Concepedia

Cheryl D. Bradshaw

CD

2

Publications

309

Citations

2

H-Index

2012

Active since

Affiliations

Esperion Therapeutics (United States)(Current)

Cheryl D. Bradshaw is an author at Esperion Therapeutics (United States) specializing in oxidative stress, atherosclerosis, and immune regulation.

Top concepts

MedicineAutophagyImmunologyAutoimmunityCell BiologyInflammationPharmacologyCell SignalingAtherosclerosisOxidative Stress

Publications per year

2012–2013

2

Publications

2

AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism

Stephen L. Pinkosky, Jeffrey C. Hanselman, Cheryl D. Bradshaw et al. · Journal of Lipid Research · 2012 · 225 citations · Full text

ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK

Stephen L. Pinkosky, Richard J. Lister, Catherine Pawloski et al. · Journal of Lipid Research · 2013 · 84 citations · Full text

Lipid Peroxidation, Immunology, Immune Regulation +20

Rows per page

1–2 of 2